Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.

ESMO 2010

8 - 12 Oct 2010

Hotel Porto Bay Falesia, Algarve, Portugal

CHOICE study and the importance of quality assurance in oncology

Prof Simon van Belle - University Hospital Ghent, Ghent, Belgium

CHOICE study and the importance of quality assurance in oncology ( Prof Simon van Belle - University Hospital Ghent, Ghent, Belgium )

The Spectrum Study

Prof Jan Vermorken – Antwerp University Hospital, Edegem, Belgium

The Spectrum Study ( Prof Jan Vermorken – Antwerp University Hospital, Edegem, Belgium )

Denosumab treatment of skeletal related events

Prof Allan Lipton - Hershey Medical Center, Pennsylvania, USA

Denosumab treatment of skeletal related events ( Prof Allan Lipton - Hershey Medical Center, Pennsylvania, USA )

The role of bevacizumab in the treatment of ovarian cancer

Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger - Fox Chase Cancer Center, Philadelphia, USA; Prof Nicoletta Colombo - European Institute of Oncology, Milan, Italy

The role of bevacizumab in the treatment of ovarian cancer ( Dr Amit Oza - Princess Margaret Hospital, Toronto, Cancada; Dr Robert Burger - Fox Chase Cancer Center, Philadelphia, USA; Prof Nicoletta Colombo - European Institute of Oncology, Milan, Italy )

Treatment of brain metastases in melanoma patients

Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands

Treatment of brain metastases in melanoma patients ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France; Prof Alexander Eggermont - Erasmus University of Rotterdam, Netherlands )

Tumour immunology and combined immunotherapies

Prof Ignacio Melero - University of Navarra, Pamplona, Spain

Tumour immunology and combined immunotherapies ( Prof Ignacio Melero - University of Navarra, Pamplona, Spain )

Supportive care for patients with locally advanced disease

Prof Dirk Schrijvers - Ziekenhuisnetwerk Antwerpen Middelheim, Antwerp, Belgium

Supportive care for patients with locally advanced disease ( Prof Dirk Schrijvers - Ziekenhuisnetwerk Antwerpen Middelheim, Antwerp, Belgium )

SPECTRUM trial for squamous cell carcinoma of the head and neck

Dr Marshall Posner - Mount Sinai School of Medicine, New York, USA

SPECTRUM trial for squamous cell carcinoma of the head and neck ( Dr Marshall Posner - Mount Sinai School of Medicine, New York, USA )

A new treatment for fractured vertebrae and the antiemetic efficacy of palonosetron

Prof Fausto Roila - Terni Hospital, Italy

$A new treatment for fractured vertebrae and the antiemetic efficacy of palonosetron ( Prof Fausto Roila - Terni Hospital, Italy )$

Molecular biomarkers and acquired resistance to new target agents

Dr Luca Toschi - Istituto Clinico Humanitas, Milan, Italy

Molecular biomarkers and acquired resistance to new target agents ( Dr Luca Toschi - Istituto Clinico Humanitas, Milan, Italy )

Clinical benefits and side effects of ipilimumab in melanoma patients

Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy

Clinical benefits and side effects of ipilimumab in melanoma patients ( Prof. Giorgio Parmiani - Fondazione San Raffaele del Monte Tabor, Milan, Italy )

Active monitoring of prostate cancer

Prof Sten Nilsson - Karolinska Institutet, Stockholm, Sweden

Active monitoring of prostate cancer ( Prof Sten Nilsson - Karolinska Institutet, Stockholm, Sweden )

Oncotype DX testing to determine adjuvant therapy for breast cancer patients

Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain

Oncotype DX testing to determine adjuvant therapy for breast cancer patients ( Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain )

Soft Tissue Sarcoma management in Turkey

Berksoy Sahin - Çukurova University Medical School, Adana-Turkey

Soft Tissue Sarcoma management in Turkey ( Berksoy Sahin - Çukurova University Medical School, Adana-Turkey )

The East European Sarcoma Group

Alexander Fedenko - N. N. Blokhin Cancer Research Centre, Moscow

The East European Sarcoma Group ( Alexander Fedenko - N. N. Blokhin Cancer Research Centre, Moscow )

Oncotype DX testing to determine adjuvant therapy for breast cancer patients

Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain

Oncotype DX testing to determine adjuvant therapy for breast cancer patients ( Prof Joan Albanell Mestres - IMIM-Hospital del Mar, Barcelona, Spain )

Clinical trials evaluating treatment of colorectal cancer

Prof Alberto Sobrero - San Martino Hospital, Genoa, Italy

Clinical trials evaluating treatment of colorectal cancer ( Prof Alberto Sobrero - San Martino Hospital, Genoa, Italy )

Patient needs that should be met by patient advocates and web resources

ECCO's Patient Advisory Committee

Patient needs that should be met by patient advocates and web resources ( ECCO's Patient Advisory Committee )

Accurate balanced reporting of cancer information

ECCO's Patient Advisory Committee

Accurate balanced reporting of cancer information ( ECCO's Patient Advisory Committee )

Influence of electronic media on the communication of cancer issues

ECCO's Patient Advisory Committee

Influence of electronic media on the communication of cancer issues ( ECCO's Patient Advisory Committee )

Media reporting of cancer

ECCO's Patient Advisory Committee

Media reporting of cancer ( ECCO's Patient Advisory Committee )

Treatment of neuroendocrine tumours with everolimus

Dr Nicola Fazio - European Institute of Oncology, Milan, Italy

Treatment of neuroendocrine tumours with everolimus ( Dr Nicola Fazio - European Institute of Oncology, Milan, Italy )

The development of PARP inhibitors a new drug to treat prostate cancer

Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK

The development of PARP inhibitors a new drug to treat prostate cancer ( Dr Johann de Bono - The Institute of Cancer Research & Royal Marsden Hospital, Surrey, UK )

How to select targeted therapy in renal cancer

Prof Bernard Escudier - Institut Gustave Roussy, Paris, France

How to select targeted therapy in renal cancer ( Prof Bernard Escudier - Institut Gustave Roussy, Paris, France )

Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer

Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain

Cardiotoxicity and predictive biomarkers for metastatic colorectal cancer ( Prof Josep Tabernero - Vall d'Hebron Institute of Oncology, Barcelona, Spain )

The impact of mapping the human genome on cancer therapies

Dr Kevin Davies - Bio-IT World, Massachusetts, USA

The impact of mapping the human genome on cancer therapies ( Dr Kevin Davies - Bio-IT World, Massachusetts, USA )

Bevacizumab as part of standard first line treatment of ovarian cancer

Prof Jonathan Ledermann - University College London, UK

Bevacizumab as part of standard first line treatment of ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )

Pain management and the treatment of cancer patients with low blood counts

Prof Dorothy Keefe - The University of Adelaide, Australia

Pain management and the treatment of cancer patients with low blood counts ( Prof Dorothy Keefe - The University of Adelaide, Australia )

GOG-218: Bevacizumab plus standard chemo for ovarian cancer

Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA

GOG-218: Bevacizumab plus standard chemo for ovarian cancer ( Prof Rob Coleman - University of Texas M.D. Anderson Cancer Center, Houston, USA )

Implementation of ESMO guidelines

Prof Andrés Cervantes - University of Valencia, Spain

Implementation of ESMO guidelines ( Prof Andrés Cervantes - University of Valencia, Spain )

A multimedia information service for cancer patients

Prof Francesco De Lorenzo - Federico II University of Naples, Italy

A multimedia information service for cancer patients ( Prof Francesco De Lorenzo - Federico II University of Naples, Italy )

A new partnership between OECI and ecancer.tv

Dr Claudio Lombardo - National Institute for Cancer Research of Genoa, Italy and Alleanza Contro il Cancro, Rome, Italy

A new partnership between OECI and ecancer.tv ( Dr Claudio Lombardo - National Institute for Cancer Research of Genoa, Italy and Alleanza Contro il Cancro, Rome, Italy )

The role of genetic testing within oncology

Dr James Mackay - University College London, UK

The role of genetic testing within oncology ( Dr James Mackay - University College London, UK )

Optimal treatment for colorectal cancer patients with liver metastases

Prof Peter Naredi - Umea University, Sweden

Optimal treatment for colorectal cancer patients with liver metastases ( Prof Peter Naredi - Umea University, Sweden )

The role of The Christie NHS Foundation Trust within OECI

Dr Chris Harrison - The Christie NHS Foundation Trust, Manchester, UK

The role of The Christie NHS Foundation Trust within OECI ( Dr Chris Harrison - The Christie NHS Foundation Trust, Manchester, UK )

The treatment of advanced pancreatic neuroendocrine tumours (pNET)

Prof Kjell Öberg - University Hospital, Uppsala, Sweden

The treatment of advanced pancreatic neuroendocrine tumours (pNET) ( Prof Kjell Öberg - University Hospital, Uppsala, Sweden )

OECI Accreditation

Dr Mahasti Saghatchian - Institut Gustave Roussy, Villejuif, France

OECI Accreditation ( Dr Mahasti Saghatchian - Institut Gustave Roussy, Villejuif, France )

Clinical trial design, biomarkers development and the treatment of neuropathic pain

Dr Marina Garassino - Fatebenefratelli Hospital, Milan, Italy

Clinical trial design, biomarkers development and the treatment of neuropathic pain ( Dr Marina Garassino - Fatebenefratelli Hospital, Milan, Italy )

Eastern Europe breast cancer screening programme

Dr. Natalia Zakharova - State Research Institute of Genetics, Moscow, Russia

Eastern Europe breast cancer screening programme ( Dr. Natalia Zakharova - State Research Institute of Genetics, Moscow, Russia )

Cancer of unknown primary origin

Prof Nicholas Pavlidis - University of Ioannina, Greece

Cancer of unknown primary origin ( Prof Nicholas Pavlidis - University of Ioannina, Greece )

PARP inhibitors

Prof Ruth Plummer - Newcastle University, UK

PARP inhibitors ( Prof Ruth Plummer - Newcastle University, UK )

The ICON7 trial

Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK

The ICON7 trial ( Prof Timothy Perren - Leeds Teaching Hospitals NHS Trust, UK )

Care of cancer survivors

Prof Wim van Harten - Netherlands Cancer Institute, Amsterdam, Netherlands

Care of cancer survivors ( Prof Wim van Harten - Netherlands Cancer Institute, Amsterdam, Netherlands )

Key research from ESMO 2010

Prof Jim Cassidy - University of Glasgow, UK

Key research from ESMO 2010 ( Prof Jim Cassidy - University of Glasgow, UK )

The ESMO President discusses the congress and future plans for developing countries

Prof David Kerr - President of ESMO

The ESMO President discusses the congress and future plans for developing countries ( Prof David Kerr - President of ESMO )

ESMO highlights from Prof Gordon McVie - his views on the science presented

Prof Gordon McVie - European Institute of Oncology

ESMO highlights from Prof Gordon McVie - his views on the science presented ( Prof Gordon McVie - European Institute of Oncology )

More from ecancer